The use of angiotensin-converting enzyme inhibitors in congestive heart failure

Cardiovascular Drugs and Therapy
J L RouleauJ de Champlain

Abstract

The development of angiotensin-converting enzyme (ACE) inhibitors has been important in furthering our understanding of the pathophysiology of congestive heart failure and improving the care of these patients. ACE inhibitors have been shown to improve the longevity and quality of life of patients with congestive heart failure. They decrease neurohumoral over-activation, they restore baroreceptor reactivity, and in many cases they increase sodium and water excretion. If hypovolemia and an excessive decrease in renal perfusion pressure can be avoided, ACE inhibitors generally do not cause a deterioration of renal function and may even improve it. By decreasing myocardial metabolic demand, ACE inhibitors appear to have generally beneficial effects on myocardial metabolic balance. At low perfusion pressures, they also appear to maintain cerebral blood flow.

References

Jan 1, 1977·Progress in Cardiovascular Diseases·K Chatterjee, W W Parmley
Jan 1, 1987·Journal of Cardiovascular Pharmacology·H M McAlpineH J Dargie
Jul 14, 1988·The New England Journal of Medicine·M A PfefferE Braunwald
Sep 15, 1985·The American Journal of Cardiology·M W WebsterJ E Wells
Oct 1, 1985·British Heart Journal·B P McGrathC I Johnston
Jan 1, 1986·European Journal of Clinical Pharmacology·B P McGrath, L F Arnolda
Oct 2, 1986·The New England Journal of Medicine·M PackerN Medina
Jan 1, 1987·Clinical and Experimental Hypertension. Part A, Theory and Practice·S KuboT Takatsu
Apr 1, 1986·European Journal of Clinical Investigation·O B PaulsonJ Godtfredsen
Nov 1, 1984·Circulation Research·I IchikawaB M Brenner
Sep 1, 1984·Annals of Internal Medicine·G S FrancisJ N Cohn
Jun 19, 1980·The New England Journal of Medicine·V J DzauN K Hollenberg
Jul 22, 1982·The New England Journal of Medicine·M R BristowE B Stinson
Sep 1, 1982·Circulation Research·T J Moore, G H Williams
May 31, 1984·The American Journal of Medicine·O B PaulsonS Vorstrup
Jan 1, 1983·Journal of the American College of Cardiology·K Chatterjee, W W Parmley

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.